Page last updated: 2024-08-26

lysophosphatidic acid and Astrocytoma, Grade IV

lysophosphatidic acid has been researched along with Astrocytoma, Grade IV in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Amaral, RF; E Spohr, TCLS; Einicker-Lamas, M; Geraldo, LHM; Lima, FRS; Mendes, F1
Bobko, A; Geldenhuys, WJ; Griffin, CL; Loskutov, YV; Margaryan, NV; Marinak, KM; Pugacheva, EN; Sarkaria, JN1
Herr, DR; Ong, JH; Ong, WY1
Burgess, A; Drummond, K; Kaye, AH; Morokoff, A; Ng, W; Pébay, A1
Tabuchi, S1
Aoki, J; Arai, H; Fujimaki, T; Hama, K; Kishi, Y; Kitayama, J; Okudaira, S; Shida, D; Tanaka, M; Yamori, T1

Reviews

3 review(s) available for lysophosphatidic acid and Astrocytoma, Grade IV

ArticleYear
Potential Therapeutic Applications for Inhibitors of Autotaxin, a Bioactive Lipid-Producing Lysophospholipase D, in Disorders Affecting the Nervous System.
    ACS chemical neuroscience, 2018, 03-21, Volume: 9, Issue:3

    Topics: Animals; Glioblastoma; Humans; Lysophospholipids; Multienzyme Complexes; Nervous System; Phosphoric Diester Hydrolases; Signal Transduction

2018
Complexities of lysophospholipid signalling in glioblastoma.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2014, Volume: 21, Issue:6

    Topics: Animals; Brain Neoplasms; Cell Movement; Glioblastoma; Humans; Lysophospholipids; Neovascularization, Pathologic; Signal Transduction

2014
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Lipids in health and disease, 2015, Jun-18, Volume: 14

    Topics: Animals; Cell Movement; Glioblastoma; Humans; Lysophospholipids; Molecular Targeted Therapy; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid

2015

Other Studies

3 other study(ies) available for lysophosphatidic acid and Astrocytoma, Grade IV

ArticleYear
Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
    Journal of neurochemistry, 2021, Volume: 156, Issue:4

    Topics: Animals; Brain Neoplasms; Cell Movement; Cell Proliferation; Cells, Cultured; Female; Glioblastoma; Humans; Lysophospholipids; Male; Mice; Microglia; Receptors, Lysophosphatidic Acid

2021
LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.
    Oncogene, 2018, Volume: 37, Issue:11

    Topics: Animals; Antineoplastic Agents; Astrocytes; Brain Neoplasms; Cell Proliferation; Cilia; Glioblastoma; Humans; Lysophospholipids; Male; Mice; Mice, Inbred NOD; Mice, Transgenic; Molecular Targeted Therapy; Receptors, Lysophosphatidic Acid; Signal Transduction; Xenograft Model Antitumor Assays

2018
Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    The Journal of biological chemistry, 2006, Jun-23, Volume: 281, Issue:25

    Topics: Blotting, Western; Brain; Cell Line, Tumor; Cell Movement; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysophosphatidylcholines; Lysophospholipids; Models, Biological; Multienzyme Complexes; Phosphodiesterase I; Phosphoric Diester Hydrolases; Pyrophosphatases; Time Factors; Transfection

2006